Literature DB >> 20495627

Importance of nutritional management in diseases with exocrine pancreatic insufficiency.

Johann Ockenga1.   

Abstract

Exocrine pancreatic insufficiency (EPI) resulting from conditions such as chronic pancreatitis (CP), acute pancreatitis (AP) and upper gastrointestinal (GI) surgery increases risk for malnutrition and metabolic problems. Poor nutrition is associated with more complications and higher mortality. Therefore, effective nutritional management should be a high priority in these patients. In CP, poor nutrition has been shown to significantly affect quality of life and functional status. Clinical study data show that dietary counselling combined with pancreatic enzyme replacement therapy is effective in improving nutritional status and is therefore recommended in these patients. In AP, early enteral nutrition reduces complications and mortality. However, EPI persists in many cases after the resolution of AP; these patients remain at increased risk for malnutrition and require further nutritional support. In patients undergoing surgery, preoperative weight loss is a risk factor for postoperative morbidity and mortality; outcomes can be improved considerably by preoperative screening to identify high-risk patients and by providing appropriate perioperative nutritional support. Pre- and perioperative enteral nutrition are cost-effective interventions that can improve outcomes in patients undergoing GI surgery. In all of these patient populations, nutritional management, including risk assessment and individualized nutritional support, is a key component of an effective multimodal therapeutic approach.

Entities:  

Year:  2009        PMID: 20495627      PMCID: PMC2798168          DOI: 10.1111/j.1477-2574.2009.00134.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  24 in total

1.  EuroOOPS: an international, multicentre study to implement nutritional risk screening and evaluate clinical outcome.

Authors:  Janice Sorensen; Jens Kondrup; Jacek Prokopowicz; Marc Schiesser; Lukas Krähenbühl; Rémy Meier; Martin Liberda
Journal:  Clin Nutr       Date:  2008-05-27       Impact factor: 7.324

2.  Bone mineral metabolism, bone mineral density, and body composition in patients with chronic pancreatitis and pancreatic exocrine insufficiency.

Authors:  A B Haaber; A M Rosenfalck; B Hansen; J Hilsted; S Larsen
Journal:  Int J Pancreatol       Date:  2000-02

3.  Randomised trial of safety and efficacy of postoperative enteral feeding in patients with severe pancreatitis: preliminary report.

Authors:  G Pupelis; E Austrums; A Jansone; R Sprucs; H Wehbi
Journal:  Eur J Surg       Date:  2000-05

Review 4.  Preoperative immunonutrition: cost-benefit analysis.

Authors:  Marco Braga; Luca Gianotti
Journal:  JPEN J Parenter Enteral Nutr       Date:  2005 Jan-Feb       Impact factor: 4.016

5.  Transluminal endoscopic necrosectomy after acute pancreatitis: a multicentre study with long-term follow-up (the GEPARD Study).

Authors:  H Seifert; M Biermer; W Schmitt; C Jürgensen; U Will; R Gerlach; C Kreitmair; A Meining; T Wehrmann; T Rösch
Journal:  Gut       Date:  2009-03-11       Impact factor: 23.059

6.  A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer.

Authors:  Luca Gianotti; Marco Braga; Luca Nespoli; Giovanni Radaelli; Aldo Beneduce; Valerio Di Carlo
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

7.  Long-term outcome after resection for chronic pancreatitis in 224 patients.

Authors:  Hartwig Riediger; Ulrich Adam; Eva Fischer; Tobias Keck; Frank Pfeffer; Ulrich T Hopt; Frank Makowiec
Journal:  J Gastrointest Surg       Date:  2007-08       Impact factor: 3.452

8.  Pancreatic enzyme replacement therapy: exocrine pancreatic insufficiency after gastrointestinal surgery.

Authors:  J Enrique Domínguez-Muñoz
Journal:  HPB (Oxford)       Date:  2009-12       Impact factor: 3.647

9.  Dietary counseling versus dietary supplements for malnutrition in chronic pancreatitis: a randomized controlled trial.

Authors:  Siddharth Singh; Shallu Midha; Namrata Singh; Yogendra Kumar Joshi; Pramod Kumar Garg
Journal:  Clin Gastroenterol Hepatol       Date:  2008-03       Impact factor: 11.382

Review 10.  What is the best way to feed patients with pancreatitis?

Authors:  Paul E Marik
Journal:  Curr Opin Crit Care       Date:  2009-04       Impact factor: 3.687

View more
  9 in total

1.  Pancreatic enzyme therapy for pancreatic exocrine insufficiency.

Authors:  J Enrique Domínguez-Muñoz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-06

2.  Pancreatic Function in Chronic Pancreatitis: A Cohort Study Comparing 3 Methods of Detecting Fat Malabsorption and the Impact of Short-term Pancreatic Enzyme Replacement Therapy.

Authors:  Jefferson N Brownell; Joan I Schall; Virginia A Stallings
Journal:  Pancreas       Date:  2019-09       Impact factor: 3.327

Review 3.  Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian Association for the Study of the Pancreas.

Authors:  Raffaele Pezzilli; Angelo Andriulli; Claudio Bassi; Gianpaolo Balzano; Maurizio Cantore; Gianfranco Delle Fave; Massimo Falconi
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

Review 4.  Introduction and practical approach to exocrine pancreatic insufficiency for the practicing clinician.

Authors:  Mohamed O Othman; Diala Harb; Jodie A Barkin
Journal:  Int J Clin Pract       Date:  2018-02-05       Impact factor: 2.503

5.  Bone metabolism and incretin hormones following glucose ingestion in young adults with pancreatic insufficient cystic fibrosis.

Authors:  Wang Shin Lei; Marissa J Kilberg; Babette S Zemel; Ronald C Rubenstein; Clea Harris; Saba Sheikh; Andrea Kelly; Joseph M Kindler
Journal:  J Clin Transl Endocrinol       Date:  2022-09-03

6.  Influences of exocrine pancreatic insufficiency on nutrient digestibility, growth parameters as well as anatomical and histological morphology of the intestine in a juvenile pig model.

Authors:  Dana Carina Schubert; Anne Mößeler; Bianca Ahlfänger; Marion Langeheine; Ralph Brehm; Christian Visscher; Amr Abd El-Wahab; Josef Kamphues
Journal:  Front Med (Lausanne)       Date:  2022-09-09

7.  Russian Consensus on Exo- and Endocrine Pancreatic Insufficiency After Surgical Treatment.

Authors:  Igor E Khatkov; Igor V Maev; Sayyar R Abdulkhalov; Sergey A Alekseenko; Ruslan B Allikhanov; Igor G Bakulin; Natalia V Bakulina; Andrey U Baranovskiy; Ekaterina V Beloborodova; Elena A Belousova; Sergey E Voskanyan; Lyudmila V Vinokurova; Vladimir B Grinevich; Vladimir V Darvin; Elena A Dubtsova; Tatiana G Dyuzheva; Vyacheslav I Egorov; Mikhail G Efanov; Roman E Izrailov; Vyacheslav L Korobka; Bogdan N Kotiv; Nikolay Yu Kokhanenko; Yury A Kucheryavy; Maria A Livzan; Vladimir K Lyadov; Karine A Nikolskaya; Marina F Osipenko; Victor D Pasechnikov; Ekaterina Yu Plotnikova; Oleg A Sablin; Vladimir I Simanenkov; Victor V Tsvirkun; Vladislav V Tsukanov; Alexey V Shabunin; Dmitry S Bordin; Professional Medical Society Pancreatic Club Russia
Journal:  Turk J Gastroenterol       Date:  2021-03       Impact factor: 1.852

8.  Screening and risk factors of exocrine pancreatic insufficiency in critically ill adult patients receiving enteral nutrition.

Authors:  Sheng Wang; Lijie Ma; Yugang Zhuang; Bojie Jiang; Xiangyu Zhang
Journal:  Crit Care       Date:  2013-08-07       Impact factor: 9.097

9.  Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis.

Authors:  Juan Enrique Domínguez-Muñoz; Laura Nieto-Garcia; Javier López-Díaz; Jose Lariño-Noia; Ihab Abdulkader; Julio Iglesias-Garcia
Journal:  BMC Cancer       Date:  2018-05-05       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.